Ioflupane I 123 Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with ioflupane I 123
R
- Rapiflux (fluoxetine)
- Recede (benzphetamine)
- Redux (dexfenfluramine)
- Regimex (benzphetamine)
- Reglan (metoclopramide)
- Relexxii (methylphenidate)
- Repreve (ropinirole)
- Requip (ropinirole)
- Requip XL (ropinirole)
- Resaid (chlorpheniramine / phenylpropanolamine)
- Rexulti (brexpiprazole)
- Rhindecon (phenylpropanolamine)
- Rhinocaps (acetaminophen / aspirin / phenylpropanolamine)
- Rhinolar (chlorpheniramine / methscopolamine / phenylpropanolamine)
- Rhinolar-EX (chlorpheniramine / phenylpropanolamine)
- Rhinolar-EX 12 (chlorpheniramine / phenylpropanolamine)
- Risperdal (risperidone)
- Risperdal Consta (risperidone)
- Risperdal M-Tab (risperidone)
- risperidone
- Risvan (risperidone)
- Ritalin (methylphenidate)
- Ritalin LA (methylphenidate)
- Ritalin-SR (methylphenidate)
- Rolatuss with Hydrocodone (hydrocodone / pheniramine / phenylephrine / phenylpropanolamine / pyrilamine)
- Rolatuss-SR (atropine / chlorpheniramine / hyoscyamine / phenylephrine / phenylpropanolamine / scopolamine)
- ropinirole
- rotigotine
- Ru-Tuss with Hydrocodone (hydrocodone / pheniramine / phenylephrine / phenylpropanolamine / pyrilamine)
- Rykindo (risperidone)
- Rymed-TR (guaifenesin / phenylpropanolamine)
More about ioflupane I 123
- ioflupane I 123 consumer information
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: diagnostic radiopharmaceuticals
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.